Skip to content

Abbott Laboratories Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 21, 2026 results vs estimates

Abbott Laboratories · E.ABT.NYSE · United States
Use symbol E.ABT.NYSE in our API & Excel add-in to retrieve this data ↓
104.57
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 0%
Bubble Risk LOW
Realised Volatility (20D) 22.54%

Abbott Laboratories Forecast

Abbott Laboratories short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is neutral (4 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term NEUTRAL signal. Based on 20-day realised volatility of 22.5% a year, a typical one-standard-deviation range is 101.25–107.89 over a week, 97.76–111.38 over a month and 81.00–128.14 over a year. (Signals as of 1 Nov 2026.)

Abbott Laboratories Price Chart

MacroFinance.ai

Abbott Laboratories Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Abbott Laboratories
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Abbott Laboratories
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Abbott Laboratories
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Abbott Laboratories
P/E
38.66x
Stretched vs own history
QoQ +3.2%
YoY +141.1%
now 38.658313.44 low40.64 high
ⓘP/E As of 22 Nov 2026.See Abbott Laboratories returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Abbott Laboratories
P/S
3.77x
Cheap vs own history
QoQ −13.7%
YoY −26.3%
now 3.76813.26 low5.14 high
ⓘP/S As of 22 Nov 2026.See Abbott Laboratories returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Abbott Laboratories
P/B
3.56x
Cheap vs own history
QoQ −10.5%
YoY −19.0%
now 3.56152.83 low4.42 high
ⓘP/B As of 22 Nov 2026.See Abbott Laboratories returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Abbott Laboratories
EV/EBITDA
18.84x
Mid-range vs own history
QoQ −7.3%
YoY −3.1%
now 18.841513.78 low20.33 high
ⓘEV/EBITDA As of 22 Nov 2026.See Abbott Laboratories returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Abbott Laboratories
EV/Sales
4.33x
Mid-range vs own history
QoQ −12.5%
YoY −17.3%
now 4.32513.73 low5.26 high
ⓘEV/Sales As of 22 Nov 2026.See Abbott Laboratories returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Abbott Laboratories
FCF Yield
3.7%
Mid-range vs own history
QoQ −3.4%
YoY +20.4%
now 3.71813.07 low5.01 high
ⓘFCF Yield As of 22 Nov 2026.See Abbott Laboratories returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Abbott Laboratories
Earnings Yield
2.6%
Weak vs own history
QoQ −3.1%
YoY −58.5%
now 2.58682.46 low7.44 high
ⓘEarnings Yield As of 22 Nov 2026.See Abbott Laboratories returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Abbott Laboratories
Dividend Yield
2.4%
Strong vs own history
QoQ +13.5%
YoY +31.8%
now 2.37931.79 low2.84 high
ⓘDividend Yield As of 22 Nov 2026.See Abbott Laboratories returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Abbott Laboratories
Market Cap
$181.7B
Mid-range vs own history
QoQ −10.6%
YoY −18.9%
now 181732.8304147,307 low225,446 high
ⓘMarket Cap As of 22 Nov 2026.See Abbott Laboratories returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Abbott Laboratories
Net Debt
$26.9B
High vs own history
QoQ −0.5%
YoY +415.8%
now 268615,208 low27,005 high
ⓘNet Debt As of 22 Nov 2026.See Abbott Laboratories returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Abbott Laboratories
Net Debt / EBITDA
2.43x
High vs own history
QoQ +1.8%
YoY +449.6%
now 2.42620.44 low2.43 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Abbott Laboratories returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Abbott Laboratories
Current Ratio
1.45x
Weak vs own history
QoQ +5.7%
YoY −14.6%
now 1.45471.38 low1.7 high
ⓘCurrent Ratio As of 22 Nov 2026.See Abbott Laboratories returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Abbott Laboratories
Quick Ratio
1.00x
Weak vs own history
QoQ +3.6%
YoY −19.5%
now 1.00040.97 low1.24 high
ⓘQuick Ratio As of 22 Nov 2026.See Abbott Laboratories returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Abbott Laboratories
Interest Coverage
7.72x
Weak vs own history
QoQ −38.5%
YoY −59.8%
now 7.727.72 low21.2 high
ⓘInterest Coverage As of 22 Nov 2026.See Abbott Laboratories returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Abbott Laboratories
Debt / Equity
0.61x
High vs own history
QoQ −4.3%
YoY +140.4%
now 0.61060.25 low0.65 high
ⓘDebt / Equity As of 22 Nov 2026.See Abbott Laboratories returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Abbott Laboratories
Piotroski F-Score
5
Mid-range vs own history
QoQ 0.0%
YoY −28.6%
now 55 low7 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Abbott Laboratories returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Abbott Laboratories
Altman Z-Score
3.32
Weak vs own history
QoQ −5.3%
YoY −43.9%
now 3.31662.9 low5.93 high
ⓘAltman Z-Score As of 22 Nov 2026.See Abbott Laboratories returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Abbott Laboratories, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Abbott Laboratories fundamentals: income statement, balance sheet & cash flow

Abbott Laboratories reported revenue of $44.33bn and net income of $6.52bn in FY2025, the year ended 31 December 2025 — revenue up 5.7% and net income down 51.3% on the prior year. Free cash flow was $7.40bn. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$44.33bn
+5.7%
Net income
$6.52bn
-51.3%
Gross margin
55.51%
Free cash flow
$7.40bn
+16.4%
Net debt
$6.55bn
Shares short (30 Oct 2026)
19.06m
1.91 days to cover
Abbott Laboratories income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue44.3341.9540.1143.6543.08
Cost of revenue19.7220.6320.0721.3319.86
Gross profit24.6121.3320.0422.3223.21
Research & development2.962.822.722.852.74
Selling, general & admin.—11.70—11.0111.32
Operating income8.056.836.448.369.20
EBITDA11.9210.8310.6111.8912.16
Interest expense0.340.600.700.320.41
Pre-tax income8.477.016.668.318.21
Income tax1.94-6.390.941.371.14
Net income6.5213.405.726.937.07

Download Abbott Laboratories fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.ABT.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Abbott Laboratories

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Abbott Laboratories Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Abbott Laboratories; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Abbott Laboratories’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Abbott Laboratories behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Abbott Laboratories (United States)

Abbott Laboratories is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Abbott Laboratories

Frequently asked questions

What is Abbott Laboratories?
Abbott Laboratories is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Abbott Laboratories price?
The latest close is 104.57 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Abbott Laboratories in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is neutral (4 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Abbott Laboratories?
20-day realised volatility is 22.5% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 6.5% over a month and 3.2% over a week.
What factors affect Abbott Laboratories?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Abbott Laboratories, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Abbott Laboratories?
58 backtested tactical asset allocation strategies trade Abbott Laboratories through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Abbott Laboratories returns analysed?
The Statistical Distribution of Returns section shows the distribution of Abbott Laboratories daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Abbott Laboratories historical data?
In the Free historical data section of this page: the last 10 years of Abbott Laboratories daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Abbott Laboratories historical data (last 10 years)

Browse or instantly download the last 10 years of Abbott Laboratories daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ABT.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20103
2026-11-19103.87
2026-11-18104.48
2026-11-17104.71
2026-11-16107.45
2026-11-13108.52
2026-11-12107.25
2026-11-11109.29
2026-11-10110.46
2026-11-09110.51
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.